16th Mar 2015 09:50
LONDON (Alliance News) - Oxford BioMedica PLC Monday said Chief Development Officer Paul Blake bought 97,560 shares at a price of 10.25 pence per share on Friday.
Following this transaction, Blake holds 2.6 million shares, which represents 0.1% of the issued share capital.
Shares in the gene and cell therapy company were up 0.5% at 10.18p Monday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica